Rhazes, pionir koji je pridonio istraživanju u medicinskoj praksi

Medical history explains that Persian physicians used scientific methods based on clinical experiences and observations for treatment from pre-Islamic time (before 637 AD) and centuries later (in the Islamic era). Rhazes was one of the Persian physicians acknowledged as a pharmacist, chemist and prominent scientific writer on various subjects of medicine and philosophy. In this study, we aimed to investigate clinical experiences, as well as the ethical and critical views of Rhazes in medical practice. Rhazes promoted ethics in the medical profession. He expressed critical key points about ancient written texts. He broke ancient physicians’ taboos in medical theories and evaluated them based on his own experiences. He designed animal and preclinical evaluations for his theories and also performed the first clinical trials with control groups in the history. His critical views about medical sciences as well as his beliefs in experiments resulted in many medical, chemical and pharmaceutical findings. Therefore, in history, he can be considered as the pioneer in using trials and experiments for approving medical methods.Medicinska povijest pokazuje da su se perzijski liječnici služili znanstvenim metodama u liječenju, temeljenim na kliničkim iskustvima i promatranjima još od predislamskog vremena (prije 637. godine) i stoljećima poslije (u islamskom dobu). Rhazes je bio jedan od perzijskih liječnika priznat kao ljekarnik, kemičar i istaknuti znanstveni pisac o različitim temama iz medicine i filozofije. U ovom radu nastojali smo istražiti klinička iskustva, kao i etičke i kritičke stavove Rhazesa u medicinskoj praksi. Rhazes je promovirao etiku u medicinskoj struci. Iznio je kritične ključne točke o antičkim pisanim tekstovima. Srušio je drevne liječničke tabue u medicinskim teorijama i procijenio ih na temelju vlastita iskustva. Provodio je evaluacije za svoje teorije na životinjama i u predklinici te proveo i prva klinička ispitivanja s kontrolnim grupama u povijesti. Njegova kritička stajališta o medicinskim znanostima, kao i vjerovanje u eksperimente rezultirali su mnogim medicinskim, kemijskim i farmaceutskim otkrićima. Stoga se Rhazesa u povijesti može smatrati pionirom u korištenju ispitivanja i eksperimenata za odobravanje medicinskih metoda

Rhazes, pionir koji je pridonio istraživanju u medicinskoj praksi

Medical history explains that Persian physicians used scientific methods based on clinical experiences and observations for treatment from pre-Islamic time (before 637 AD) and centuries later (in the Islamic era). Rhazes was one of the Persian physicians acknowledged as a pharmacist, chemist and prominent scientific writer on various subjects of medicine and philosophy. In this study, we aimed to investigate clinical experiences, as well as the ethical and critical views of Rhazes in medical practice. Rhazes promoted ethics in the medical profession. He expressed critical key points about ancient written texts. He broke ancient physicians’ taboos in medical theories and evaluated them based on his own experiences. He designed animal and preclinical evaluations for his theories and also performed the first clinical trials with control groups in the history. His critical views about medical sciences as well as his beliefs in experiments resulted in many medical, chemical and pharmaceutical findings. Therefore, in history, he can be considered as the pioneer in using trials and experiments for approving medical methods.Medicinska povijest pokazuje da su se perzijski liječnici služili znanstvenim metodama u liječenju, temeljenim na kliničkim iskustvima i promatranjima još od predislamskog vremena (prije 637. godine) i stoljećima poslije (u islamskom dobu). Rhazes je bio jedan od perzijskih liječnika priznat kao ljekarnik, kemičar i istaknuti znanstveni pisac o različitim temama iz medicine i filozofije. U ovom radu nastojali smo istražiti klinička iskustva, kao i etičke i kritičke stavove Rhazesa u medicinskoj praksi. Rhazes je promovirao etiku u medicinskoj struci. Iznio je kritične ključne točke o antičkim pisanim tekstovima. Srušio je drevne liječničke tabue u medicinskim teorijama i procijenio ih na temelju vlastita iskustva. Provodio je evaluacije za svoje teorije na životinjama i u predklinici te proveo i prva klinička ispitivanja s kontrolnim grupama u povijesti. Njegova kritička stajališta o medicinskim znanostima, kao i vjerovanje u eksperimente rezultirali su mnogim medicinskim, kemijskim i farmaceutskim otkrićima. Stoga se Rhazesa u povijesti može smatrati pionirom u korištenju ispitivanja i eksperimenata za odobravanje medicinskih metoda

Rhazes, pionir koji je pridonio istraživanju u medicinskoj praksi

Medical history explains that Persian physicians used scientific methods based on clinical experiences and observations for treatment from pre-Islamic time (before 637 AD) and centuries later (in the Islamic era). Rhazes was one of the Persian physicians acknowledged as a pharmacist, chemist and prominent scientific writer on various subjects of medicine and philosophy. In this study, we aimed to investigate clinical experiences, as well as the ethical and critical views of Rhazes in medical practice. Rhazes promoted ethics in the medical profession. He expressed critical key points about ancient written texts. He broke ancient physicians’ taboos in medical theories and evaluated them based on his own experiences. He designed animal and preclinical evaluations for his theories and also performed the first clinical trials with control groups in the history. His critical views about medical sciences as well as his beliefs in experiments resulted in many medical, chemical and pharmaceutical findings. Therefore, in history, he can be considered as the pioneer in using trials and experiments for approving medical methods.Medicinska povijest pokazuje da su se perzijski liječnici služili znanstvenim metodama u liječenju, temeljenim na kliničkim iskustvima i promatranjima još od predislamskog vremena (prije 637. godine) i stoljećima poslije (u islamskom dobu). Rhazes je bio jedan od perzijskih liječnika priznat kao ljekarnik, kemičar i istaknuti znanstveni pisac o različitim temama iz medicine i filozofije. U ovom radu nastojali smo istražiti klinička iskustva, kao i etičke i kritičke stavove Rhazesa u medicinskoj praksi. Rhazes je promovirao etiku u medicinskoj struci. Iznio je kritične ključne točke o antičkim pisanim tekstovima. Srušio je drevne liječničke tabue u medicinskim teorijama i procijenio ih na temelju vlastita iskustva. Provodio je evaluacije za svoje teorije na životinjama i u predklinici te proveo i prva klinička ispitivanja s kontrolnim grupama u povijesti. Njegova kritička stajališta o medicinskim znanostima, kao i vjerovanje u eksperimente rezultirali su mnogim medicinskim, kemijskim i farmaceutskim otkrićima. Stoga se Rhazesa u povijesti može smatrati pionirom u korištenju ispitivanja i eksperimenata za odobravanje medicinskih metoda

Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series

Background: Coronavirus disease 2019 (COVID-19) pandemic has raised concerns about the susceptibility amongst different groups of the population. Pregnant women are one such group. This study was conducted to investigate the effect of COVID-19 on pregnancy and maternal/neonatal outcomes. Case presentation: This case series was conducted on 16 pregnant women with COVID-19 from March 21 to May 11, 2020. Clinical characteristics, pregnancy complications, medication used, maternal/neonatal outcomes, and fatality rate were investigated through this study. The mean age of the patients was 30.06 yrs. Patients from all three trimesters were included (1 in first, 5 in second, and 10 in the third trimesters). The most common clinical symptoms were shortness of breath (n = 10), dry cough (n = 10), myalgia (n = 8), and chills (n = 7). Also, three cases had papulosquamous skin lesions with fissuring. The most common laboratory results were leukocytosis (n = 8), increased liver enzymes (n = 6), elevated CRP (n = 5), and thrombocytopenia (n = 4). There was one case of maternal mortality, five of premature labor pain (PLP), two of preeclampsia, and two of placenta accreta. Twelve pregnancies were terminated (nine cesarean sections, three vaginal deliveries). Among neonates, we had 6 cases of preterm labor. All neonates had negative PCR results. Conclusion: Clinical manifestations and paraclinical results were similar to nonpregnant patients. There was no evidence of vertical transmission. PLP and premature rupture of membranes (PROM) were the most common complications in the second and third trimesters of pregnant COVID-19 women, which can lead to rupture of the uterus. Termination and delivery should be planned individually. Key words: Pregnancy, COVID-19, Maternal-fetal infection transmission, Vertical transmission of infectious disease, Papulosquamous skin diseases

Assessment of hospitalization and mortality of scleroderma in-patients: a thirteen-year study

Objective: Systemic sclerosis (SSc) is an uncommon non-hereditary sporadic disease that increases the risk of premature death, especially in diffuse type. We determined the prevalence of SSc in the last 13 years in our rheumatologic hospitals as a referral center for southern Iranian patients, the causes of hospitalization, the average length of stay (LOS), the mortality rate, and the reason for their mortality. Material and methods : A cross-sectional study was performed in Shiraz University of Medical Sciences, Iran. The studied population included all patients diagnosed with systemic sclerosis. We calculated the hospitalization rates, in-hospital mortality rates, and mean LOS. Results: There were 446 admissions by 181 patients with SSc. The female to male ratio was about 10.7 : 1. The overall mean LOS was 5.95 days. Digital ulcer and interstitial lung disease (ILD) were the most common causes of hospitalizations among the SSc-related events. For those with a non-SSc-related condition, infection was the most prevalent event. Most of the deaths were due to ILD and pulmonary artery hypertension(PAH), and the overall in-hospital mortality rate was 16.5%. Conclusions : Women with SSc had higher rates of hospitalization but lower in-hospital mortality than men.There were some differences between our study and other similar studies in the causes of hospitalization and in-hospital death among SSc patients, especially the lower age of death. The patients with digital ulcers and those with intestinal lung disease or pulmonary hipertension were most commonly admitted to the hospital in our study group. Probably, increasing the skin care of these patients and asking other specialty groups to cooperate will decrease the high rate of hospitalizations in our population

استاد دکتر عبدالله خان احمديه احیاگر طب سنتی بالینی ایران

Doctor Abdullah Khan Ahmadieh was born in Amol city at 1265 Hijri and he was graduated in medicine from the Darolfonoon Academy at 1294 Hijri. He started to working in Darolfonoon School of medicine as one of distinguished professors in natural history and parasitology. Dr. Ahmadieh tried hardly to treat patients via traditional medicine methods and modern medicine if necessary. Current paper briefly describes the life of Dr. Ahmadieh and his view about various medical schools and their methods of treatment. Two books have been remained from him, called (Secret of treatment) and (Treatment of rheumatism, gout and sciatica). In these books, he has sincerely written his experiences with presenting of patients histories, prescriptive drugs and their effects.دکتر عبدالله خان احمدیه در سال 1265 هجری شمسی در آمل به دنیا آمده و در سال 1294 در رشته طب از دارالفنون فارغ‌التحصیل شدند و به عنوان یکی از اساتید برجسته‌ی مدرسه پزشکی دارالفنون به عنوان استاد تاریخ طبیعی و انگل‌شناسی مشغول به کار گردیدند. دکتر احمدیه با تلاش فراوان سعی در درمان بیماران با کمک روش‌های طب سنتی و در صورت لزوم طب امروزی می‌کردند. مقاله حاضر به اختصار به شرح زندگی‌نامه دکتر احمدیه و دیدگاه وی نسبت به مکاتب مختلف پزشکی و روش طبابتشان می‌پردازد. از دکتر احمدیه دو کتاب با نام‌های (راز درمان) و (درمان روماتیسم، نقرس و سیاتیک) به یادگار مانده است. در این آثار ایشان با اخلاصی در خور تحسین به بیان تجربیات شخصی خود با ارائه شرح‌حال بیماران، داروهای تجویزی و اثرات آن‌ها پرداخته است

Comparison of the bactericidal efficacy of photodynamic therapy, 2.5% sodium hypochlorite, and 2% chlorhexidine against Enterococcous faecalis in root canals; an in vitro study

Background : Enterococcus faecalis has been widely used as a valuable microbiological pathogen for in vitro studies due to its ability to successfully colonize the root canal in a biofilm-like style, invade dentinal tubules, and resist endodontic treatment procedures.The aim of this study was to compare the bactericidal efficacy of photodynamic therapy (PDT), 2% chlorhexidine, 2.5% NaOCl, and combination of PDT and 2.5% NaOCl against E. faecalis. Materials and Methods: Sixty single-rooted teeth had their canals contaminated with E. faecalis in brain heart infusion broth and were incubated for 48 hours.The canals were then subjected to 2% chlorhexidine, 2.5% NaOCl, PDT (red light emitting diode 625 nm+ Toludine Blue) and PDT + 2.5% NaOCl. Controls consisted of no treatment (positive control) and without inoculation of bacterium (negative control). Following treatment, the canal contents were sampled with sterile paper points.The samples were dispersed in transport medium, serially diluted, and cultured on blood agar to determine the number of colony forming units (CFU). Data were analyzed by Mann-Whitney U test at 5% significance level. The significance level for all analyses was set at P <.05. Results: Combination of PDT and 2.5% NaOCl achieved maximum reduction in recovered viable bacteria, no viable bacteria was observed after treatment of PDT + 2.5% NaOCl. Conclusion: Combination of PDT and 2.5% NaOCl simultaneously is effective in the elimination of E. faecalis from dentinal tubules under the conditions of this study